Hauser Chemical Research entering nutraceutical, food ingredient areas.
This article was originally published in The Tan Sheet
Executive Summary
HAUSER CHEMICAL ENTERING NUTRACEUTICALS, FOOD INGREDIENTS AREAS as the firm continues to rebuild its business after losing its primary supply agreement -- the supply of bulk paclitaxel to Bristol-Myers Squibb for the Taxol anticancer drug -- in the fourth quarter of fiscal 1995 (ended April 30). Hauser's new Nutraceuticals Division has begun selling products and is producing a rosemary antioxidant formula, the firm reported.
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning